<DOC>
	<DOCNO>NCT01425697</DOCNO>
	<brief_summary>The purpose study see use 2 % Chlorhexidine cloth reduce surgical site infection patient elective cardiac surgery .</brief_summary>
	<brief_title>Eliminate Risk Cardiac Surgical Site Events</brief_title>
	<detailed_description>A randomize , prospective study utilize 2 % Chlorhexidine cloths evaluate product 's effectiveness reduce surgical site infection elective cardiothoracic surgery patient . Sage 2 % chlorhexidine cloth approve Food Drug Administration ( FDA ) preparation skin prior surgery . The study hypothesis preoperative surgical preparation 2 % chlorhexidine cloth , leave chlorhexidine skin , reduce surgical site infection 50 % compare current standard procedure .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Surgical Wound Infection</mesh_term>
	<mesh_term>Chlorhexidine gluconate</mesh_term>
	<mesh_term>Chlorhexidine</mesh_term>
	<criteria>Elective cardiothoracic surgery patient &gt; 18 year old . Informed consent obtain Any current know allergy chlorhexidine gluconate Currently take oral topical antibiotic Any active skin rash break skin area treat chlorhexidine gluconate A current active skin disease inflammatory skin condition , know preexist skin infection , include contact dermatitis currently treat antibiotic Any medical condition use medication opinion Principal Investigator preclude participation . Unwillingness failure fulfill requirement study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>Adult Cardiac surgery</keyword>
	<keyword>Surgery site infection</keyword>
</DOC>